EZH2 and hepatocellular carcinoma: Using data from the TCGA-LIHC cohort accessed via the UALCAN platform, both mRNA and protein expression levels of EZH2 were found to be significantly elevated in hepatocellular carcinoma (HCC) tissues compared to normal liver tissues (Figure 1A and 1C).